| Customization: | Available |
|---|---|
| CAS No.: | 2152628-33-4 |
| Formula: | C29h31n7o3 |
|
Still deciding? Get samples of US$ 50/gram
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
CAS: 2152628-33-4
MF: C29H31N7O3
Molecular Weight: 525.6
Synoyms: LOXO292, Selpercatinib, LY3527723, CPD2206
Selpercatinib powder is the raw, powdered form of the active pharmaceutical ingredient (API) Selpercatinib, which is used to formulate the targeted cancer therapy drug. Selpercatinib is a tyrosine kinase inhibitor (TKI) that specifically targets cancers with mutations or fusions in the RET gene.
The powdered form of Selpercatinib is typically used during the drug's manufacturing process before being converted into a final product, such as capsules or tablets. It contains the same chemical compound that inhibits the abnormal RET proteins involved in the growth and survival of certain cancer cells.
1. Pharmaceutical Manufacturing
Selpercatinib powder serves as the primary active ingredient in the production of cancer medications. It is processed and formulated into final dosage forms, such as capsules or tablets, for use in targeted therapies. These medications are prescribed to patients with RET-driven cancers.
2. Cancer Treatment
Once formulated into a drug, Selpercatinib is used to treat specific cancers, such as:
RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC): In patients with advanced or metastatic NSCLC who have RET gene fusions.
RET-Mutant Medullary Thyroid Cancer (MTC): For both adults and children over 12 with RET-mutated advanced or metastatic MTC.
RET Fusion-Positive Thyroid Cancer: For patients with advanced or metastatic thyroid cancer that is not responding to radioactive iodine treatment.
3. Preclinical and Clinical Research
In its powdered form, Selpercatinib is used in research settings for the development and testing of cancer therapies. Researchers may study its mechanism of action, optimize dosages, and assess its efficacy in treating RET-driven cancers.
4. Pharmaceutical Development
Selpercatinib powder is also used in developing new formulations of the drug or combination therapies. It enables pharmaceutical companies to explore ways to improve drug delivery, increase bioavailability, and reduce side effects in future versions of the medication.
Shandong Longilat Biotechnology Co., Ltd was established in 2015. It is a high-tech professional and technological enterprise integrating R & D, production, and sales.
Longilat 's main products are food additives, plant extracts, cosmetic raw materials, feed additives, animal extract, amino acids and vitamins. Most of our products are derived from natural plants. Marketing services are available in many countries around the world.
1.Can I get some samples?
Yes, usually a 10-20g sample.
2.What's your MOQ?
Our MOQ is flexible, usually 1kg-10kg for a trial order is acceptable.
3. Is there a discount?
Of course, welcome to contact us. Price would be different based on different quantities. For bulk quantity, we will have a discount for you.
4. How to deliver the goods?
≤50kg ship by FedEx or DHL etc, ≥50kg ship by Air, ≥100kg can be shipped by Sea. If you have special request on delivery, please contact us.
5. What is the shelf life for the products?
Most products shelf life 24-36 months.
6. What's your delivery time?
Usually, shipment will be made within 7-15 days against confirmed order.
7. How about the validity of the offer?
Usually, our offer is valid for 1 week. However, validity might vary between different products.
){kind=link}